Vaginal microbiome and cervical cancer

M Kyrgiou, AB Moscicki - Seminars in Cancer Biology, 2022 - Elsevier
The female reproductive tract, similar to other mucosal sites, harbors a specific microbiome
commonly dominated by Lactobacillus species (spp.), which has an essential role in …

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

ETH Fontham, AMD Wolf, TR Church… - CA: a cancer journal …, 2020 - Wiley Online Library
Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

[HTML][HTML] The projected timeframe until cervical cancer elimination in Australia: a modelling study

MT Hall, KT Simms, JB Lew, MA Smith… - The Lancet Public …, 2019 - thelancet.com
Summary Background In 2007, Australia was one of the first countries to introduce a national
human papillomavirus (HPV) vaccination programme, and it has since achieved high …

Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045

Y Zhang, C Fakhry, G D'Souza - JAMA oncology, 2021 - jamanetwork.com
Importance Oropharynx cancer (OPC) incidence has increased for several decades in the
US. It is unclear when and how this trend will be affected by current HPV vaccination trends …

[HTML][HTML] Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics

T Jiang, T Yang, Y Chen, Y Miao, Y Xu, H Jiang… - Theranostics, 2022 - ncbi.nlm.nih.gov
The occurrence of microorganisms has been confirmed in the tumor microenvironment
(TME) of many different organs. Microorganisms (eg, phage, virus, bacteria, fungi, and …

Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study

H Damgacioglu, K Sonawane, J Chhatwal… - The Lancet Regional …, 2022 - thelancet.com
Background Oropharyngeal cancer (OPC) incidence is rising rapidly among men in the
United States of America (USA). We aimed to project the impact of maintaining the current …

Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
Background: In the United States, the routine age for human papillomavirus (HPV)
vaccination is 11 to 12 years, with catch-up vaccination through age 26 years for women and …

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis

JJ Kim, KT Simms, J Killen, MA Smith, EA Burger… - PLoS …, 2021 - journals.plos.org
Background A nonavalent human papillomavirus (HPV) vaccine has been licensed for use
in women and men up to age 45 years in the United States. The cost-effectiveness of HPV …

Medical students' knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer

EY Du, E Adjei Boakye, DB Taylor… - Human Vaccines & …, 2022 - Taylor & Francis
On the basis of their training, medical students are considered “the best case scenario”
among university students in knowledge of the human papillomavirus (HPV). We evaluated …

Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study

PE Castle, WK Kinney, X Xue, LC Cheung… - Annals of internal …, 2018 - acpjournals.org
Background: Current US cervical cancer screening and management guidelines do not
consider previous screening history, because data on multiple-round human papillomavirus …